Tapering of inhaled corticosteroids in stable T2-low asthma: a randomized trial of symptom- and biomarker trajectories
Premature trial termination due to recruitment challenges reflects the rarity of stable T2-low asthma. ICS tapering was not associated with greater symptom deterioration compared to SoC, although non-inferiority was not demonstrated.
Authors
- Christian Grabow Westergaard
- Lasse K. Bak (ORCID: https://orcid.org/0000-0003-0784-7864)
- Christiane Hammershaimb E. Mosbech
- I Christiansen (ORCID: https://orcid.org/0000-0001-6115-2890)
- Charlotte Suppli Ulrik (ORCID: https://orcid.org/0000-0001-8689-3695)
- Nina Godtfredsen (ORCID: https://orcid.org/0000-0003-1468-2869)
Institutions
- University of Copenhagen (DK)
- Hvidovre Hospital (DK)
- Copenhagen University Hospital (DK)
- Rigshospitalet (DK)
Publication Details
- Journal
- Journal of Asthma
- Published
- 2025-10-29
- DOI
- https://doi.org/10.1080/02770903.2025.2581018
- Primary Topic
- Asthma and respiratory diseases
- Type
- article
- Field-Weighted Citation Impact
- 0.00